Skip to content
2000
Volume 7, Issue 1
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Recent findings in animals and in humans have shown that cannabinoid type 1 receptor antagonists are suitable to become the most promising validated class of drugs to tackle obesity and related disorders. This mini-review will provide a concise and updated revision of the state of art on this topic.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955707779317812
2007-01-01
2024-11-14
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955707779317812
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test